Related references
Note: Only part of the references are listed.Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
Andras Ladanyi et al.
ONCOGENE (2018)
Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins
Sandra Guaita-Esteruelas et al.
MOLECULAR CARCINOGENESIS (2017)
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual et al.
NATURE (2017)
The role of Vimentin in Regulating Cell Invasive Migration in Dense Cultures of Breast Carcinoma Cells
Yonatan Messica et al.
NANO LETTERS (2017)
Exogenous lipids promote the growth of breast cancer cells via CD36
Jing Zhao et al.
ONCOLOGY REPORTS (2017)
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Activation of Peroxisome Proliferator-activated Receptor (PPARγ) and CD36 Protein Expression THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE
Xiaoxiao Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-DEPENDENT MECHANISM
Miao Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications
Valeria Simone et al.
ONCOLOGIST (2016)
Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice
Yuanli Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2
Xuewei Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial
Jack Cuzick et al.
LANCET ONCOLOGY (2015)
Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer
Muralidharan Anbalagan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Endocrine resistance in breast cancer - An overview and update
Robert Clarke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma
Aritro Nath et al.
SCIENTIFIC REPORTS (2015)
Cancer Stem Cell-Specific Scavenger Receptor CD36 Drives Glioblastoma Progression
James S. Hale et al.
STEM CELLS (2014)
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells
A. Noto et al.
CELL DEATH & DISEASE (2013)
Stable Inhibition of Specific Estrogen Receptor α (ERα) Phosphorylation Confers Increased Growth, Migration/Invasion, and Disruption of Estradiol Signaling in MCF-7 Breast Cancer Cells
B. P. Huderson et al.
ENDOCRINOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
RAC1 activation mediates Twist1-induced cancer cell migration
Wen-Hao Yang et al.
NATURE CELL BIOLOGY (2012)
Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc
C. Elizabeth Caldon et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Is obesity an independent prognosis factor in woman breast cancer?
Bilal Majed et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36°/apoE° mice
Ella Guy et al.
ATHEROSCLEROSIS (2007)
Twenty-year follow-up of the royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial
Trevor J. Powles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Obesity as a risk factor for development and poor prognosis of breast cancer
A. R. Carmichael
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Estradiol down-regulates CD36 expression in human breast cancer cells
IP Uray et al.
CANCER LETTERS (2004)
Ki67 antigen and PCNA proliferation markers predict survival in anorectal malignant melanoma
O Ben-Izhak et al.
HISTOPATHOLOGY (2002)
Mechanisms of tamoxifen-induced apoptosis
S Mandlekar et al.
APOPTOSIS (2001)
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
M Febbraio et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Transforming growth factor-β1 (TGF-β1) and TGF-β2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-γ
JH Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
